Pediatric asthma control during the COVID-19 pandemic
- PMID: 33657264
- PMCID: PMC8014816
- DOI: 10.1002/iid3.418
Pediatric asthma control during the COVID-19 pandemic
Abstract
Background: The lockdown imposed by the COVID-19 pandemic resulted in a completely different style of life with possible effects on the attitude toward their disease in patients with chronic lung disease, such as asthma. The aim of our study was to investigate in asthmatic children the level of asthma control and the maintenance therapy used during the lockdown.
Methods: Among asthmatic children attending our clinic, we identified those who had been prescribed the same therapy in March-April 2019 and March-April 2020. The level of asthma control (GINA-score) and the maintenance therapy used during the lockdown (March-April 2020) were compared with those of March-April 2019. We separately analyzed a small group of children with severe asthma treated with Omalizumab during the lockdown.
Results: We enrolled 92 asthmatic children (67 males). Compared to 2019, in 2020 a higher proportion of children modified their maintenance therapy (38% vs. 15.2%, p < .001), with a significant increase in both the proportion of children who increased (p = .033) and in that of children who decreased their therapy (p = .026). The level of control resulted as significantly higher in 2020 (March p = .023; April p = .007). Also, the 13 children treated with Omalizumab showed a good level of control in 2020.
Conclusions: In asthmatic children, the COVID-19 pandemic lockdown had a significant impact on their asthma control and on their attitude toward maintenance therapy.
Keywords: COVID-19 lockdown; COVID-19 pandemic; asthma control; maintenance therapy; pediatric asthma.
© 2021 The Authors. Immunity, Inflammation and Disease published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare that there are no conflict of interests.
Figures
Similar articles
-
Safety of biological therapy in children and adolescents with severe asthma during the COVID-19 pandemic: a case series.Acta Biomed. 2022 Jun 6;93(S3):e2022053. doi: 10.23750/abm.v93iS3.13073. Acta Biomed. 2022. PMID: 35666117 Free PMC article.
-
'Real-life' experience in asthmatic children treated with omalizumab up to six-years follow-up.Allergol Immunopathol (Madr). 2019 Jul-Aug;47(4):336-341. doi: 10.1016/j.aller.2018.09.009. Epub 2018 Nov 30. Allergol Immunopathol (Madr). 2019. PMID: 30509559
-
COVID-19 in a patient with severe asthma treated with Omalizumab.Allergy. 2020 Oct;75(10):2705-2708. doi: 10.1111/all.14456. Epub 2020 Jun 27. Allergy. 2020. PMID: 32544254 Free PMC article. No abstract available.
-
Omalizumab and long-term quality of life outcomes in patients with moderate-to-severe allergic asthma: a systematic review.Ther Adv Respir Dis. 2019 Jan-Dec;13:1753466619841350. doi: 10.1177/1753466619841350. Ther Adv Respir Dis. 2019. PMID: 31035904 Free PMC article.
-
Pediatric severe asthma: a case series report and perspectives on anti-IgE treatment.BMC Pediatr. 2018 Feb 21;18(1):73. doi: 10.1186/s12887-018-1019-9. BMC Pediatr. 2018. PMID: 29466963 Free PMC article. Review.
Cited by
-
Youth and caregiver asthma functioning and quality of life throughout the COVID-19 pandemic.Front Allergy. 2023 Sep 4;4:1268112. doi: 10.3389/falgy.2023.1268112. eCollection 2023. Front Allergy. 2023. PMID: 37731770 Free PMC article.
-
The impact of COVID-19 lockdown on children with recurrent wheezing and asthma in Spain.J Paediatr Child Health. 2022 Sep;58(9):1635-1641. doi: 10.1111/jpc.16068. Epub 2022 Jun 24. J Paediatr Child Health. 2022. PMID: 35748401 Free PMC article.
-
Pediatric asthma control during the COVID-19 pandemic: A systematic review and meta-analysis.Pediatr Pulmonol. 2022 Jan;57(1):20-25. doi: 10.1002/ppul.25736. Epub 2021 Nov 18. Pediatr Pulmonol. 2022. PMID: 34672436 Free PMC article.
-
Reduced asthma morbidity during COVID-19 in minority children: is medication adherence a reason?J Asthma. 2023 Mar;60(3):468-478. doi: 10.1080/02770903.2022.2059510. Epub 2022 Apr 5. J Asthma. 2023. PMID: 35341432 Free PMC article.
-
Acute events in children with sickle cell disease in Italy during the COVID-19 pandemic: useful lessons learned.Br J Haematol. 2021 Sep;194(5):851-854. doi: 10.1111/bjh.17546. Epub 2021 May 25. Br J Haematol. 2021. PMID: 34036565 Free PMC article. No abstract available.
References
-
- Coronavirus Emergency: The National response . Dipartimento della Protezione Civile. http://www.protezionecivile.gov.it/en/risk-activities/health-risk/emerge.... Accessed August 7, 2020.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous